Litigation Details for Indivior Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Indivior Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-04-03 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 9,687,454; 9,931,305 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Indivior Inc. v. Actavis Laboratories UT, Inc.
Details for Indivior Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-05-14 | 71 | Opinion - Memorandum Opinion | infringement of U.S. Patent Nos. 9,931,305 ("the '305 patent") and 9,687,454 ("the '…construction for multiple terms in U.S. Patent Nos. 9,931,305 and 9,687,454. Signed by Judge Richard G. Andrews…construction of multiple terms in U.S. Patent Nos. 9,931,305 and 9,687,454. The Court has considered the Parties…#39;454 patent"). (D.I. 1, 6). The '454 patent concerns "self-supporting dosage forms which… dosage form." ('454 patent, abstract). The '305 patent concerns "rapid dissolve | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |